 not decrease the rate of perioperative stroke,
but it was associated with an increased incidence of
postoperative MI and congestive heart failure.146
Because this study investigated intraoperative dextran
use, an objective assessment of the clinical risk/beneÔ¨Åt
ratio of postoperative dextran is not possible. There is
clearly no Level 1 evidence to recommend for or against
use of dextran among patients undergoing CEA, so this
should be a